HL7 Terminology (THO)
7.4.11 - Continuous Process Integration (ci build) International flag

HL7 Terminology (THO), published by HL7 International - Vocabulary Work Group. This guide is not an authorized publication; it is the continuous build for version 7.4.11 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/UTG/ and changes regularly. See the Directory of published versions

CodeSystem: Detected Issue Clinical Impact

Official URL: http://terminology.hl7.org/CodeSystem/detectedissue-clinical-impact Version: 1.0.0
Standards status: Trial-use Maturity Level: 3 Responsible: Health Level Seven International Computable Name: DetectedIssueClinicalImpact

Copyright/Legal: This material derives from the HL7 Terminology (THO). THO is copyright ©1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see: https://terminology.hl7.org/license

Codes that describe the potential clinical impact of a detected issue.

This Code system is referenced in the definition of the following value sets:

This case-sensitive code system http://terminology.hl7.org/CodeSystem/detectedissue-clinical-impact defines the following codes:

CodeDisplayDefinition
increased-effect Increased effect The clinical or pharmacologic effect is expected to be increased for one or more implicated therapies.
decreased-effect Decreased effect The clinical or pharmacologic effect is expected to be decreased for one or more implicated therapies.
mixed-effect Mixed effect Mixed or differing changes in clinical or pharmacologic effects are expected.
adverse-reaction Adverse reaction An adverse reaction is expected or its risk is increased.
additive-adverse-effects Additive adverse effects Adverse or undesirable effects are expected to be additive for one or more implicated therapies.
avoid-concurrent-use Avoid concurrent use when possible Concurrent use should generally be avoided because of the identified clinical risk.
contraindicated-in-some-patients Contraindicated in some patients Concurrent use is contraindicated for a subset of patients based on patient-specific clinical characteristics or circumstances.

Description of the above table(s).

History

DateActionAuthorCustodianComment
2026-10-25createBryn RhodesCDSCreate Detected Issue Clinical Impact Code System; up-864